Renal Dysfunction Influences the Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin I
- PMID: 29079658
- PMCID: PMC5791068
- DOI: 10.1681/ASN.2017030341
Renal Dysfunction Influences the Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin I
Abstract
Measures of cardiac troponin (cTn) may have lower specificity for myocardial infarction in patients with CKD. We examined the diagnostic accuracy of baseline and serial high-sensitivity cTnI (hs-cTnI) measurements for myocardial infarction and 30- and 180-day mortality according to renal function. hs-cTnI was measured (Abbott assay) using sex-specific 99th percentiles (women, 16 ng/L; men, 34 ng/L) in 1555 adults presenting to the emergency department with symptoms suggesting ischemia (NCT02060760). Myocardial infarction was adjudicated along universal definition classification. Renal function did not significantly affect sensitivity or negative predictive values. Specificity decreased with impaired renal function from 93%-95% with normal function (eGFR≥90 ml/min per 1.73 m2; n=722) to 57%-61% with severely impaired renal function (eGFR<30 ml/min per 1.73 m2; n=81) and 40%-41% on dialysis (n=78). Positive predictive values decreased with decreasing renal function from 51%-57% with normal function to 27%-42% with severely impaired function and 15%-32% on dialysis. Receiver operating characteristic curve areas trended lower at baseline and 3 hours with renal impairment. Mortality increased significantly with increasing hs-cTnI tertile (1.3%, 6.0%, and 10.4%, respectively). Patients with hs-cTnI concentration exceeding concentrations in the 99th percentiles had a mortality rate (11.7%) significantly higher than that of patients with concentrations between 99th percentile concentrations and limit of detection (6.2%) or below limit of detection (1.1%). Renal dysfunction and dialysis reduced the rule-in performance but not the rule-out performance of hs-cTnI for myocardial infarction, and mortality increased in patients with higher hs-cTnI concentrations and any level of renal dysfunction.
Keywords: cardiac troponin; chronic kidney disease; myocardial infarction; outcomes.
Copyright © 2018 by the American Society of Nephrology.
Figures
Similar articles
-
Validation of presentation and 3 h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction.Heart. 2016 Aug 15;102(16):1270-8. doi: 10.1136/heartjnl-2015-308505. Epub 2016 Mar 8. Heart. 2016. PMID: 26955848
-
Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction.Circulation. 2017 Oct 17;136(16):1495-1508. doi: 10.1161/CIRCULATIONAHA.117.028084. Epub 2017 Sep 26. Circulation. 2017. PMID: 28972002 Free PMC article.
-
High-sensitive cardiac troponin for the diagnosis of acute myocardial infarction in different chronic kidney disease stages.BMC Cardiovasc Disord. 2021 Feb 17;21(1):100. doi: 10.1186/s12872-020-01746-0. BMC Cardiovasc Disord. 2021. PMID: 33596833 Free PMC article.
-
Performance of high-sensitivity cardiac troponin in the emergency department for myocardial infarction and a composite cardiac outcome across different estimated glomerular filtration rates.Clin Chim Acta. 2018 Apr;479:166-170. doi: 10.1016/j.cca.2018.01.034. Epub 2018 Feb 3. Clin Chim Acta. 2018. PMID: 29366835 Clinical Trial.
-
Sex-Specific Versus Overall Clinical Decision Limits for Cardiac Troponin I and T for the Diagnosis of Acute Myocardial Infarction: A Systematic Review.Clin Chem. 2018 Jul;64(7):1034-1043. doi: 10.1373/clinchem.2018.286781. Epub 2018 May 29. Clin Chem. 2018. PMID: 29844245 Review.
Cited by
-
Kidney function-specific cut-off values of high-sensitivity cardiac troponin T for the diagnosis of acute myocardial infarction.Clin Kidney J. 2024 Aug 23;17(9):sfae247. doi: 10.1093/ckj/sfae247. eCollection 2024 Sep. Clin Kidney J. 2024. PMID: 39246629 Free PMC article.
-
Coronary Artery Disease in CKD-G5D Patients: An Update.Rev Cardiovasc Med. 2023 Aug 8;24(8):227. doi: 10.31083/j.rcm2408227. eCollection 2023 Aug. Rev Cardiovasc Med. 2023. PMID: 39076724 Free PMC article. Review.
-
From heart failure and kidney dysfunction to cardiorenal syndrome: TMAO may be a bridge.Front Pharmacol. 2023 Nov 21;14:1291922. doi: 10.3389/fphar.2023.1291922. eCollection 2023. Front Pharmacol. 2023. PMID: 38074146 Free PMC article. Review.
-
Long-term prognostic value of high-sensitivity cardiac troponin-I in patients with idiopathic dilated cardiomyopathy.Open Med (Wars). 2023 Nov 8;18(1):20230837. doi: 10.1515/med-2023-0837. eCollection 2023. Open Med (Wars). 2023. PMID: 38025529 Free PMC article.
-
Role of Cardiac Troponins in Predicting Adverse Outcomes in Acute Coronary Syndrome With Renal Dysfunction.Cureus. 2023 Oct 16;15(10):e47104. doi: 10.7759/cureus.47104. eCollection 2023 Oct. Cureus. 2023. PMID: 38022315 Free PMC article. Review.
References
-
- Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BR, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Botker HE, Bozkurt B, Bugiardini R, Cannon C, de Lemos J, Eberli FR, Escobar E, Hlatky M, James S, Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, Storey RF, Taubert KA, Vranckx P, Wagner DR; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction; Authors/Task Force Members Chairpersons; Biomarker Subcommittee; ECG Subcommittee; Imaging Subcommittee; Classification Subcommittee; Intervention Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; ESC Committee for Practice Guidelines (CPG); Document Reviewers : Third universal definition of myocardial infarction. J Am Coll Cardiol 60: 1581–1598, 2012 - PubMed
-
- Sandoval Y, Smith SW, Shah ASV, Anand A, Chapman AR, Love SA, Schulz K, Cao J, Mills NL, Apple FS: Rapid rule-out of acute myocardial injury using a single high-sensitivity cardiac troponin I measurement. Clin Chem 63: 369–376, 2017 - PubMed
-
- Sandoval Y, Smith SW, Love SA, Sexter A, Schulz K, Apple FS: Single high-sensitivity cardiac troponin I to rule-out acute myocardial infarction. Am J Med 130: 1076–1083, 2017 - PubMed
-
- Sandoval Y, Smith SW, Thordsen SE, Bruen CA, Carlson MD, Dodd KW, Driver BE, Jacoby K, Johnson BK, Love SA, Moore JC, Sexter A, Schulz K, Scott NL, Nicholson J, Apple FS: Diagnostic performance of high sensitivity compared with contemporary cardiac troponin I for the diagnosis of acute myocardial infarction. Clin Chem 63: 1594–1604, 2017 - PubMed
-
- deFilippi CR, Herzog CA: Interpreting cardiac biomarkers in the setting of chronic kidney disease. Clin Chem 63: 59–65, 2017 - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous